APA (7th ed.) Citation

S, M., N, T., V, P., T, P., P, F., H, T., . . . A, M. (2026). AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-26-0871

Chicago Style (17th ed.) Citation

S, Medina, et al. "AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 2026. https://doi.org/10.1158/1078-0432.CCR-26-0871.

MLA (9th ed.) Citation

S, Medina, et al. "AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2026, https://doi.org/10.1158/1078-0432.CCR-26-0871.